List of GLP-1 receptor agonists: difference between revisions
Diff·revision 1 → 2·13:35, 11 Aug 2024
Difference between revision 1 and revision 2 of List of GLP-1 receptor agonists. 2 lines changed; the page grew by 268 bytes.
| Revision 1 — 09:00, 4 Aug 2024 PortalPolly (talk) new list article, expansion welcome 1,616 bytes +1,616 | Revision 2 — 13:35, 11 Aug 2024 RetinopathyRex (talk) state plainly what this list does not cover 1,884 bytes +268 | ||
|---|---|---|---|
| 20 | | [[Orforglipron]] | Oral | Daily | Investigational | | 20 | | [[Orforglipron]] | Oral | Daily | Investigational | |
| 21 | 21 | ||
| + | 22 | The list spans three architectures: exendin-derived peptides, [[Albumin binding half-life extension|acylated]] GLP-1 analogues, an Fc fusion, and a non-peptide small molecule. See [[GLP-1 receptor agonist]] for how each solves the half-life problem.{{r|drucker2018}} | |
| + | 23 | ||
| 22 | == References == | 24 | == References == |
| 23 | {{reflist}} | 25 | {{reflist}} |